• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.61% Nasdaq Up0.40%

    Achillion Pharmaceuticals, Inc. (ACHN)

    -NasdaqGS
    8.83 Down 0.03(0.38%) 12:33PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development15,156  16,426  12,070  12,177  
    Selling General and Administrative4,243  5,235  3,694  3,589  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (19,399) (21,661) (15,764) (15,766)
    Income from Continuing Operations
    Total Other Income/Expenses Net152  79  101  117  
    Earnings Before Interest And Taxes(19,247)(21,582)(15,663)(15,649)
    Interest Expense16  14  4  8  
    Income Before Tax(19,263)(21,596)(15,667)(15,657)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(19,263)(21,596)(15,667)(15,657)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (19,263) (21,596) (15,667) (15,657)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (19,263) (21,596) (15,667) (15,657)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.